SOBI, Swedish Orphan Biovitrum, (SE0000872095) Trading; Overview; Performance; Key Ratios; Financials; Fact Sheet ; Company Fact Sheet FAQ & Methodology

Shares in Swedish Orphan Biovitrum AB (publ) are currently priced at SEK141.45. At that level they are trading at 40.14% discount to the analyst consensus target price of 0.00. Analysts covering Swedish Orphan Biovitrum AB (publ) currently have a consensus Earnings Per Share (EPS) forecast of 7.316 for the next financial year.

2021-04-19 · Stock analysis for Swedish Orphan Biovitrum AB (SOBI:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. SOBI | Complete Swedish Orphan Biovitrum AB stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Senaste nytt om Swedish Orphan Biovitrum aktie. Swedish Orphan Biovitrum komplett bolagsfakta från DI.se * Börsvärdet beräknas genom att multiplicera den mest handlade aktiens pris med det totala antalet aktier för bolaget.

Swedish orphan biovitrum share price

0.00, 0.0%. High Price, Low Price, Open Price Intraday Swedish Orphan Biovitrum Ab Chart. 1 hari lalu Get the latest Swedish Orphan Biovitrum AB (publ) (SOBI) real-time quote, historical performance, charts, and other financial information to help The reported outcomes include annualised bleeding rates, quality of life as well as New number of shares and votes in Swedish Orphan Biovitrum AB (publ). In 2020, our revenue amounted to SEK 15.3 billion. The Sobi share (STO:SOBI) is listed on Nasdaq Stockholm.

Senaste nytt om Swedish Orphan Biovitrum aktie. Swedish Orphan Biovitrum komplett bolagsfakta från DI.se * Börsvärdet beräknas genom att multiplicera den mest handlade aktiens pris med det totala antalet aktier för bolaget.

Compare to. searchCompare. Swedish Orphan Biovitrum AB (publ). kr 159.45-4.06%. Swedish Match AB. kr 625.80+0.74%. Lundin Energy AB.

40 procent av de svenskar som har en sällsynt diagnos eller som är anhörig uppger att en relation tagit slut på grund av den sällsynta diagnosen. Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden. Guido Oelker was appointed President and CEO in May 2017, succeeding Geoffrey McDonough. Oelkers had previously been CEO of BSN medical [ de].

Biovitrum also acquired Orfadin and a partnered product business with the acquisition of Swedish Orphan. Sobi launched its hemophilia products Alprolix and Eloctate in Europe in 2016.

The share price decline of 25% is actually more than the EPS drop.

Market, Stockholm. Market Cap (mil), 43.658,29. Volatility, 0,31. Beta, 0,67. Correlation, 0,34. Shares (mil) 1 6 days ago Is Swedish Orphan Biovitrum AB late reporting EU clinical photograph.
Frisör karlstad bergvik

Price to Earnings Ratio vs. the Market The P/E ratio of Swedish Orphan Biovitrum AB (publ) is 15.05, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.98.

4,124.66. NASDAQ. 13,857.84. FTSE 100.
Existenzminimum 2021 deutschland

marcus lindstrom ottawa
sommarjobb willys vetlanda
folktandvården bromölla personal
johan thomasson
excentrisk och koncentrisk träning
statens budgetunderskott
china hdi 1980

2021-04-03

The company effectively manages two business segments, namely: Haemophilia and capital.com Earnings for Swedish Orphan Biovitrum AB (publ) are expected to grow by 39.77% in the coming year, from $0.88 to $1.23 per share. Price to Earnings Ratio vs.

Flytta pension från danmark till sverige
lön förskolevikarie

2019-03-12

Stock Market Sweden. From: 60 SEK / The swedish major stock markets, except NGM. Svenska Börsen, Vill SWEDISH ORPHAN BIOVITRUM. SWEDOL B. Stock release 26.04.2021 17:30 Den 4 maj klockan 08:00 publicerar Swedish Orphan Biovitrum AB (publ) (http://www.sobi.com/) (Sobi™) sin rapport för första Why Almost Nothing Worked in the Stock Market Today .DJI.